Health Investment

Governments play a key role in ensuring the health of their population and funding the health services that influence population health. To reflect the benefits to government from investing in health technology, GMAS has pioneered the development of ‘government perspective’ health investment modelling. The methodology was originally developed by Dr. Mark Connolly, the founder of GMAS, and is based on generational accounting principles to reflect how changes in population health influence public finances.

The government perspective modelling framework treats health costs as an investment, and not just a cost. Therefore, it reflects the value of investing in medical technology as shown by the net tax revenue to government from improvement to population health status that arise from these investments.

Recognising the importance of national governments as key decision makers in health allocation decisions, the framework assesses the value of your product in a way that governments understand best - through the effect on tax revenues and workforce productivity.

This approach has been successfully applied to generate powerful value messages targeted at government decision makers in areas such as:

• Vaccination
• Reproductive medicine
• Behavioural disorders.

Seminal publications and presentations on this topic can be found on the publications page.